Secondary cvd prevention—Lipid modification strategies: A critical analysis
Authors:
- 1 November 2017
- journal article
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 11, S187-S193
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial InfarctionJACC, 2015
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsCirculation, 2014
- Lipid Profile of Patients with Acute Myocardial Infarction and its Correlation with Systemic InflammationBiomarker Insights, 2013
- Promoting Global Cardiovascular HealthCirculation, 2011
- Contribution of 30 Biomarkers to 10-Year Cardiovascular Risk Estimation in 2 Population CohortsCirculation, 2010
- Effect of Intensive Statin Therapy on Clinical Outcomes Among Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary SyndromeJACC, 2009
- Lipid Levels in the Post-Acute Coronary Syndrome Setting: Destabilizing Another Myth?JACC, 2008
- Peri-procedural myocardial injury: 2005 updateEuropean Heart Journal, 2005
- Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary DiseaseNew England Journal of Medicine, 2005
- Discovering the Full Spectrum of Cardiovascular DiseaseCirculation, 2005